These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2005-002756-18||Bortezomib consolidation in patients with myeloma following treatment with high-dose melphalan and autologous stem cell support. A randomised NMSG trial (15/05)||2010-05-01||due-trials|
|Not reported||2007-001292-11||Talidomid vs Velcade vid melfalanrefraktärt myelom||2010-12-31||due-trials|
|Ongoing||2009-017903-28||A randomized phase III study to compare Bortezomib, Melphalan, Prednisone (VMP) with High Dose Melphalan followed by Bortezomib, Lenalidomide, Dexamethasone (VRD) consolidation and Lenalidomide mainte...||not-yet-due|
|Listed as ongoing, but also has a completion date||2013-003789-15||Phase II study of carfilzomib- cyclophosphamide-dexamethasone and high-dose melphalan followed by randomization between observa-tion or maintenance with carfil-zomib and dexamethasone in pa-tients wit...||2019-09-01||bad-data|